Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement

Overview of attention for article published in Patient preference and adherence, May 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 13,940 followers.

RT @dr_kevinlee: #easd2018 background reading: review article on #GLP1 persistence (article title used "adherence") https://t.co/ZYQGqGUeSq…

#easd2018 background reading: review article on #GLP1 persistence (article title used "adherence") https://t.co/ZYQGqGUeSq https://t.co/jrM828FJ7g

RT @patientconnect1: New review: Dulaglutide, albiglutide and prolonged-release exenatide have an extended duration of action. The convenie…

RT @patientconnect1: New review: Dulaglutide, albiglutide and prolonged-release exenatide have an extended duration of action. The convenie…

RT @patientconnect1: New review: Dulaglutide, albiglutide and prolonged-release exenatide have an extended duration of action. The convenie…